Skip to Main Content
Thought Leadership

Category:

Philip Segrest, Jr.

News

Husch Blackwell Scores Victory for Sigmapharm in Hatch-Waxman Litigation

Husch Blackwell successfully defended Sigmapharm Laboratories, LLC in connection with its application for approval of a generic version of the antidepressant vortioxetine.

News Releases | October 15, 2021

Insights

IP Watchdog: TC Heartland Update: Federal Circuit decides ZTE and Bigcommerce

Erin Knese, Philip Segrest & Steve Holtshouser explore some recent Federal Circuit decisions that clarify venue issues in patent cases.

Articles | June 01, 2018